Firm at a glance
Audax Group is a platform private equity firm founded in 1999 with offices in Boston, San Francisco, Hong Kong, New York, and London, per its own website [S1].
What they buy
Based on publicly available information, Audax Group appears to pursue platform investments across six sectors: Business Services, Consumer, Financial Services, Healthcare, Industrial Services & Technologies, and Software & Technology [S1]. The firm operates a seventh flagship fund totaling $5.25 billion, with an additional $1.5 billion of GP co-investment capital, alongside an Origins strategy with over $1 billion of committed capital [S1]. This multi-fund structure suggests the firm may target businesses across different size segments, though specific deal parameters are not disclosed in public sources.
Portfolio
No current portfolio companies were surfaced in the public materials reviewed as of January 2026. The firm’s website and other public sources did not provide a comprehensive portfolio listing at the time of this review.
Recent activity (last 24 months)
– **July 2026**: Exit of StatLab Medical Products [S1]
– **June 2026**: Exit of Harbourfront Wealth [S1]
How this firm fits a seller
Audax Group’s recent exit activity in healthcare and financial services suggests experience navigating transactions in regulated industries, which may appeal to sellers seeking buyers familiar with compliance-intensive sectors [S1]. The firm’s multi-office footprint spanning North America, Europe, and Asia could indicate capacity to support businesses with international operations or expansion plans [S1]. For owner-operators in Business Services, Consumer, Financial Services, Healthcare, Industrial Services & Technologies, or Software & Technology sectors, the firm’s stated sector focus aligns with these verticals, though specific investment criteria and operational approach are not detailed in available public materials [S1].
Sources
[S1] https://www.audaxprivateequity.com (as of 2026-01-01)
Frequently asked questions
Does Audax Group buy Healthcare businesses?
Yes, Healthcare is among the six sectors Audax Group reportedly pursues [S1]. The firm’s July 2026 exit of StatLab Medical Products demonstrates recent activity in the healthcare sector [S1].
What companies has Audax Group acquired recently?
Public sources reviewed did not surface recent acquisitions in the last 24 months. The firm’s most recent disclosed transactions were exits: StatLab Medical Products in July 2026 and Harbourfront Wealth in June 2026 [S1].
Where is Audax Group based and how big is the firm?
Audax Group maintains offices in Boston, San Francisco, Hong Kong, New York, and London [S1]. The firm’s seventh flagship fund totals $5.25 billion with an additional $1.5 billion of GP co-investment capital, and its Origins strategy holds over $1 billion of committed capital, per public sources as of January 2026 [S1].
Is Audax Group still actively acquiring?
While the firm’s most recent publicly disclosed transactions in the last 24 months were exits (July 2026 and June 2026), the existence of active fund vehicles totaling over $7 billion in capital suggests ongoing investment activity [S1]. Specific acquisition announcements were not surfaced in the public materials reviewed.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.